This session will address the following points:

• Change management
• Breaking down silos
• Bridging the collaborative gap when working with other pharma
• Infrastructure and scalability
• Integrated innovation
• Regulatory barriers

 

---

If your analytics tools aren’t giving you a holistic view of your data, it’s time to rethink your strategy. After all, end-to-end analytics is the cornerstone for making accurate and data-driven decisions. Implementing effective analytics across your organization enables democratized, empowered, and faster decision making, building momentum for your digital transformation journey. Unlock the power of visualization, reporting, exploration and ML/AI enabled by highly contextualized quality data, all through the power of advanced analytics.

The IDBS Analytics platform is a game changer in the digital transformation of our industry as we ensure everyone has access to data intelligence by streamlining the user experience. The embedded IDBS Data Science platform provides our customers with a simple view, which encourages full data visualization and analytics-driven decision making. Empower your data transformation today!

---

---

In this webinar, Dassault Systèmes will present how combining molecular modelling and machine learning is essential for speeding up drug development, driving innovation and crucially supporting life science experts in their research.

This session will address:

● Leverage an open and scalable platform that brings together over 30 years of peer-reviewed research and world-class in silico techniques.

● Understand the benefits of structure-based design workflows and generative therapeutic design.

● Increase your understanding on new advances in Biologics excipients formulation

● Enhance team collaboration by enabling researchers to better share their data and make better-informed decisions in drug development.

---

---

• What is surrounding AI in biocatalysis?
• What can we do with data to enhance efficiency?
• How are we validating processes and running tests and reviewing data?
• What infrastructure challenges have been faced so far and how are we trying to overcome these hurdles
• What are the next steps for Enginzyme? 

---